Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-02-27 @ 10:39 AM
Study NCT ID:
NCT03842969
Status:
COMPLETED
Last Update Posted:
2023-08-31
First Post:
2019-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-11
First Submit QC Date:
None
Study First Post Date:
2019-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-16
Results First Submit QC Date:
None
Results First Post Date:
2023-08-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-09
Last Update Post Date:
2023-08-31
Last Update Post Date Type:
ACTUAL